Dr. Andrew David Berke, MD

Dr. Berke practices at St. Francis Hospital & Heart Center in Roslyn, New York, part of Diocese of Rockville Centre.

Dr. Berke's NPI, 1588738140, was assigned on November 17, 2006. Dr. Berke graduated from The Warren Alpert Medical School of Brown University in 1979. Dr. Berke's New York license number on file is 144686.

Dr. Berke's primary practice is St. Francis Hospital & Heart Center, at 100 Port Washington Boulevard, Roslyn, NY 11576 in Nassau County. The practice phone is (516) 562-6000.

Dr. Berke's primary practice is St. Francis Hospital & Heart Center in Roslyn, New York, part of Diocese of Rockville Centre. Dr. Berke is also affiliated with St. Catherine of Siena Hospital. The medical group on file is Cardiac Interventional Group. Dmand AI also links Dr. Berke to 1 more home health agency, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Berke practices, 3 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Berke's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Berke is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Berke has a license on file in New York.

Dmand AI lists angioplasty and cardiac catheterization among the conditions Dr. Berke treats.

CMS data shows 3,367 Medicare services from Dr. Berke across 19 procedure codes in 2024, for 825 Medicare patients. Medicare paid $314,642 for them.

CMS counts 825 Medicare patients who saw Dr. Berke in 2024. The largest group is 75 to 84, with 341 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Berke's median patient age at 78, with 36% women.

In 2024, Dr. Berke wrote 1,378 Medicare Part D claims for 167 patients. 83% of them were for generic drugs. CMS names the drug for 1,198 of them, across 35 drugs with 11 or more claims each, at $240,383 in total drug cost. In 2023, CMS named 924 claims across 27 drugs.

Dr. Berke accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 29 procedures of coronary angioplasty and stenting by Dr. Berke, more than 64% of the clinicians it reports for that procedure.

Dmand AI links 13 papers to Dr. Berke, published from 2011 to 2025. 2011 was the busiest year, with 2. The most frequent topics are Cardiac Catheterization, Atrial Function, Left and Coronary Disease. Dr. Berke has published most often in Circ Cardiovasc Imaging. Dr. Berke's most frequent co-authors are George A. Petrossian, MD, Jie Jane Cao, MD and William B. Chung, MD.

Dmand AI links Dr. Berke to 3 clinical trials. 2 are still active or recruiting. Conditions studied include Mitral Valve Insufficiency and Heart Valve Diseases. Edwards Lifesciences sponsors the most, 2.

CMS Open Payments shows 212 general payments to Dr. Berke from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 62% of the total. Edwards Lifesciences Corporation paid the most, $7,595.

Dmand AI lists 3 awards for Dr. Berke, most recently Newsday - Top Doctors on Long Island in 2014.

Dr. Berke graduated from The Warren Alpert Medical School of Brown University in 1979. Dr. Berke is a member of ACC.

Dr. Berke is in network with 17 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.